C07D 501/00
Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a
Official title: Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: [IMAGE cpc-sch-C07D-0993.gif] , e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
C07D501/00 (Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a) appears on 1,542 US grants and 424 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,542
- Published applications
- 424
- Assignees
- 326
- Inventors
- 2,168
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 112 | 0 |
| 1977 | 112 | 0 |
| 1978 | 72 | 0 |
| 1979 | 54 | 0 |
| 1980 | 43 | 0 |
| 1981 | 58 | 0 |
| 1982 | 52 | 0 |
| 1983 | 49 | 0 |
| 1984 | 49 | 0 |
| 1985 | 29 | 0 |
| 1986 | 34 | 0 |
| 1987 | 37 | 0 |
| 1988 | 35 | 0 |
| 1989 | 33 | 0 |
| 1990 | 47 | 0 |
| 1991 | 48 | 0 |
| 1992 | 49 | 0 |
| 1993 | 37 | 0 |
| 1994 | 34 | 0 |
| 1995 | 38 | 0 |
| 1996 | 49 | 0 |
| 1997 | 70 | 0 |
| 1998 | 30 | 0 |
| 1999 | 37 | 0 |
| 2000 | 25 | 0 |
| 2001 | 23 | 7 |
| 2002 | 29 | 25 |
| 2003 | 20 | 29 |
| 2004 | 17 | 36 |
| 2005 | 12 | 35 |
| 2006 | 10 | 42 |
| 2007 | 13 | 31 |
| 2008 | 18 | 24 |
| 2009 | 20 | 16 |
| 2010 | 15 | 11 |
| 2011 | 6 | 12 |
| 2012 | 13 | 12 |
| 2013 | 10 | 15 |
| 2014 | 15 | 17 |
| 2015 | 13 | 17 |
| 2016 | 11 | 15 |
| 2017 | 14 | 17 |
| 2018 | 8 | 17 |
| 2019 | 10 | 7 |
| 2020 | 9 | 9 |
| 2021 | 9 | 4 |
| 2022 | 0 | 7 |
| 2023 | 5 | 4 |
| 2024 | 1 | 9 |
| 2025 | 6 | 3 |
| 2026 | 2 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Cephalosporin antibacterial compound and preparation method therefor11 Aug 2026US 12,703,709 B2Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- Antibiotic conjugates10 Feb 2026US 12,544,384 B2University of Notre Dame du Lac
- Sulfur (VI) fluoride compounds and methods for the preparation thereof19 Aug 2025US 12,390,424 B2The Scripps Research Institute
- Siderophore cephalosporin conjugates and uses thereof29 Jul 2025US 12,371,441 B2Ariva Med GmbH
- Refining method of midbody of latamoxef sodium1 Jul 2025US 12,344,622 B2Hainan Hailing Chemipharma Corporation Ltd.
- Method for producing ß-lactam compound17 Sep 2026US 2026/0274862 A1FUJIFILM Corporation
- Quorum-sensing inhibitors and/or postbiotic metabolites and related methods7 May 2026US 2026/0124268 A1MicroSintesis Inc.
- Compositions and methods for adoptive cell therapy for cancer16 Apr 2026US 2026/0103696 A1Memorial Sloan Kettering Cancer Center
- Platform drug delivery system utilizing crystal engineering and theanine dissolution17 Jul 2025US 2025/0228778 A1Theaprin Pharmaceuticals Inc.
- Beta-Lactam-Cannabinoid Conjugate Molecules10 Jul 2025US 2025/0222118 A1Diverse Biotech, Inc.
Most cited
By later US patents
- Enzyme substrate comprising a functional dye and associated technology and methods145US 8,092,784 B2Biotium, Inc. · 2012
- Cytotoxic compounds and conjugates121US 7,517,903 B2Medarex, Inc. · 2009
- Fluorogenic substrates for .beta.-lactamase and methods of use85US 5,741,657 AThe Regents of the University of California · 1998
- 3-Acetoxymethyl-7-(iminoacetamido)-cephalosporanic acid derivatives77US 4,152,432 ARoussel Uclaf · 1979
- Syn 7-oxoimino substituted derivatives of cephalosporanic acid67US 4,166,115 AFujisawa Pharmaceutical Co., Ltd. · 1979